![]() |
|
|
Vol. 300, Issue 2, 668-672, February 2002
Department of Pharmacology, Nihon University School of Dentistry at
Matsudo, Matsudo, Japan
The effect of tenidap
[(±)-5-chloro-2,3-dihydro-3-(hydroxy-2-thienylmethylene)-2-oxo-1H-indole-1-carboxamide],
a new anti-inflammatory agent, was investigated on DNA synthesis by
means of [3H]thymidine incorporation, collagen synthesis
by means of [3H]proline incorporation, cell
proliferation, and intracellular pH in nicardipine-reactive human
gingival fibroblasts. Tenidap significantly inhibited
[3H]thymidine incorporation at concentrations greater
than 20 µM on the 4th and 8th day of treatment. Tenidap also
significantly inhibited [3H]proline incorporation at a
concentration greater than 50 µM on the 4th day and at more than 20 µM on the 8th day of treatment. The presence of 1 µM nifedipine or
1 µM nicardipine did not alter the depressing effect of tenidap.
Tenidap (20 µM) also lowered intracellular pH. These results suggest
that tenidap might be effective for the prevention of gingival
overgrowth caused by calcium channel blockers.
This article has been cited by other articles:
![]() |
S. Parry, J. Zhang, H. Koi, F. Arechavaleta-Velasco, and M. A. Elovitz Transcytosis of Human immunodeficiency virus 1 across the placenta is enhanced by treatment with tumour necrosis factor alpha. J. Gen. Virol., August 1, 2006; 87(Pt 8): 2269 - 2278. [Abstract] [Full Text] [PDF] |
||||